India’s fastest-growing solar pump manufacturer, Oswal Pump’s IPO, is open for public subscription today, June 13, 2025 and will close on June 17, 2025.
Oswal Pumps IPO is a bookbuilding issue of ₹1,387.34 crores, consisting of a fresh issue of ₹890.00 crores and an OFS (Offer for Sale) component of ₹497.34 crores. The price band is set between ₹584 and ₹614 per share.
The basis of allotment will be finalised by June 18, 2025, and the tentative listing date on BSE and NSE is June 20, 2025.
IIFL Capital Services Limited, Axis Capital Limited, Clsa India Private Limited, JM Financial Limited, and Nuvama Wealth Management Limited are the book-running lead managers, while MUFG Intime India Private Limited is the registrar for the Oswal Pumps IPO.
[13-June-2025 5:00:00 PM]
Investor Category |
Subscription (Times) |
Qualified Institutional Buyers(QIBs) |
0.08 |
Non-Institutional Investors |
0.79 |
Retail Individual Investors(RIIs) |
0.44 |
Total |
0.42 |
Utilisation of IPO Proceeds
The net proceeds from the fresh issue will be used to:
As of 13 June 2025, Oswal Pumps IPO GMP stood at ₹71. The expected listing gain is ₹685, i.e., a 11.56% gain per share over the upper price band.
Source: Business Standard Report dated 13 June, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Oswal Pumps manufactures solar-powered and grid-connected submersible and monoblock pumps, electric motors comprising induction and submersible motors, and solar modules. Between Fiscal 2022 and 2024, the company’s revenue grew at a CAGR of 45.07%
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here